RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin · 1997
[Radiologically implanted subcutaneous tunneled central venous catheters for dialysis: the course and complications].
Сравнительное исследованиеАннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kluge A, Rauber K, Rau W S
Аннотация
PURPOSE: The aim of the present study was to evaluate the efficacy of fluoroscopically controlled implantation of subcutaneous tunneled single- or double-lumen-catheters for short- and long-term dialysis.
PATIENTS AND METHODS: In total, 104 patients were implanted with either a single-lumen Demer catheter or a Permcath double-lumen catheter into the subclavian vein under fluoroscopic control.
RESULTS: In 99 of 104 cases (= 95.2%) the implantation remained without complications. Implantation-related occurrences included one pneumothorax, one mediastinal haematoma and one death. 61.5% of the indwelling catheters remained in situ for the intended duration. In 78% of the patients, dialysis was carried out to completion. 37 explantations (38.3%) were required due to various factors including infection (5), thrombosis (3), dislocation (9) and malfunction (20). The average duration of implantation was 59.1 days (range 1-851 days).
CONCLUSIONS: Fluoroscopic-controlled implantation of subcutaneous tunneled catheters for dialysis is superior to surgically implanted catheters with regard to lower rates of infections and is equally reliable in respect of rates of complication and patency. Thus, this mode of implantation is a safe and reliable alternative to other procedures as access for haemodialysis.
PATIENTS AND METHODS: In total, 104 patients were implanted with either a single-lumen Demer catheter or a Permcath double-lumen catheter into the subclavian vein under fluoroscopic control.
RESULTS: In 99 of 104 cases (= 95.2%) the implantation remained without complications. Implantation-related occurrences included one pneumothorax, one mediastinal haematoma and one death. 61.5% of the indwelling catheters remained in situ for the intended duration. In 78% of the patients, dialysis was carried out to completion. 37 explantations (38.3%) were required due to various factors including infection (5), thrombosis (3), dislocation (9) and malfunction (20). The average duration of implantation was 59.1 days (range 1-851 days).
CONCLUSIONS: Fluoroscopic-controlled implantation of subcutaneous tunneled catheters for dialysis is superior to surgically implanted catheters with regard to lower rates of infections and is equally reliable in respect of rates of complication and patency. Thus, this mode of implantation is a safe and reliable alternative to other procedures as access for haemodialysis.